Matt Robinson

Background

Matt Robinson is a Partner at TCV (Technology Crossover Ventures), where he co-leads the firm’s infrastructure software investing efforts ¹. He joined TCV in 2011 as an Associate supporting the firm’s healthcare IT and services investment efforts from the New York and Palo Alto offices ¹. He left and rejoined TCV in 2016, relocating to the firm’s New York office to focus on IT infrastructure investments ². He was promoted to Partner and has deployed over $700 million into infrastructure software companies during his tenure ³.

Prior to TCV, Robinson was an Analyst in the Global Healthcare Group at UBS Investment Bank in New York, where he advised healthcare clients on M&A, equity, and debt transactions ¹³.

Robinson holds an MBA from Harvard Business School (2014-2016) and a B.S. in Biochemistry with honors from Indiana University ¹³. Born and raised in a small town in southern Indiana, he moved to New York after college ¹. He spent the summer after earning his MBA interning at Chateau Margaux in Bordeaux ¹.

Robinson led TCV’s Associate training program, built out TCV’s NYC office, and led the firm’s giving program that raised over $200,000 for COVID relief ³. He is an avid supporter of New York art museums and LGBTQ+ nonprofits, and works with charities supporting low-income families and at-risk LGBTQ youth in New York ¹. He was named to GrowthCap’s Top 40 Under 40 Growth Investors list in 2022 ³.

He served as a Board Director at Cradlepoint from 2016 to 2020 ².

Stated Thesis

(Self-reported: These represent what Robinson says publicly about his investing approach. See Inferred Thesis for analysis of actual investment behavior.)

Robinson’s focus at TCV is infrastructure software, which he co-leads for the firm ¹. His portfolio spans cloud networking, cybersecurity, data analytics, and enterprise compliance — all categories within infrastructure software ¹.

In his GrowthCap Top 40 Under 40 profile, Robinson stated: “TCV is a special place with a long history of backing some of the world’s most innovative technology companies that have impacted all our lives. I’m grateful to the firm, my colleagues, and all the entrepreneurs I’ve had the great fortune of working with and learning from in building my career here over the past decade” ³.

TCV as a firm operates as a growth-stage investor, typically deploying $10M-$200M+ per investment. Robinson’s individual investment range is centered around a $20 million sweet spot according to Signal NFX, though he has participated in rounds of $89M to $300M at the firm level ⁴.

Inferred Thesis

The analysis below is based on 9 verified investments personally attributed to Robinson from his TCV team page ¹.

Sector concentration (based on 9 verified investments): - Cybersecurity: 3 of 9 (33%) — Vectra AI, Venafi, Devo Technology - Cloud networking / SD-WAN: 2 of 9 (22%) — Aviatrix, Silver Peak - Enterprise compliance / data governance: 1 of 9 (11%) — OneTrust - Cloud data storage: 1 of 9 (11%) — Nasuni - Infrastructure automation: 1 of 9 (11%) — HashiCorp - Wireless enterprise networking: 1 of 9 (11%) — Cradlepoint

Stage distribution: All 9 verified investments are growth-stage (Series C through Series F). Robinson does not appear to invest at seed or Series A stages. TCV’s fund size of $5.5 billion is calibrated for large growth-equity checks ⁴.

Exit track record: 4 of 9 companies (44%) have achieved exits: - Cradlepoint: acquired by Ericsson for ~$1 billion (2020) ⁵ - Silver Peak: acquired by HPE for $925 million (2020) ⁶ - HashiCorp: IPO on NASDAQ in 2021, later acquired by IBM for $6.4 billion (2025) ⁷⁸ - Venafi: acquired by Thoma Bravo (2020), then CyberArk for $1.54 billion (2024) ⁹¹⁰

Geographic pattern: Portfolio companies are US-based, with concentrations in the San Francisco Bay Area (Aviatrix, HashiCorp), Boise, ID (Cradlepoint), Salt Lake City, UT (Venafi), Boston, MA (Nasuni), San Jose, CA (Vectra AI), and Atlanta, GA (OneTrust). Devo Technology is headquartered in Cambridge, MA with origins in Spain.

Typical check size: TCV’s rounds in Robinson’s portfolio range from $89M (Cradlepoint Series C) to $300M (OneTrust Series C), with Robinson having personally deployed over $700M across his portfolio ³.

Co-investor patterns: Robinson’s deals frequently include other large growth-stage firms. Insight Partners co-invested in Aviatrix and Devo. General Atlantic and Eurazeo participated in Devo. Khosla Ventures and Accel were co-investors in Vectra. Vista Equity Partners and KKR co-invested in Nasuni ^11121314.

Notable patterns: - Strong emphasis on companies providing critical infrastructure for enterprise IT security and networking — not consumer, not fintech, not application-layer SaaS. - Multiple portfolio companies address related problems (network security, machine identity, cloud networking) suggesting deep domain conviction in the infrastructure security stack. - Preference for companies with clear market leadership positions in defined categories (Aviatrix in cloud networking, OneTrust in privacy/compliance, Venafi in machine identity). - His early career in healthcare IT at TCV and UBS did not carry forward; the pivot to infrastructure software appears complete.

Sample size caveat: This analysis is based on 9 publicly attributed investments. Robinson may have additional investments not publicly disclosed on TCV’s website.

Portfolio

Notes: HashiCorp year is approximate; TCV is listed as a HashiCorp investor and Robinson is credited with the investment ¹, but the specific round TCV entered is not confirmed in press coverage. The TCV website lists Zach Riedy as the TCV contact for HashiCorp ⁷, suggesting Robinson may have been involved earlier in a supporting capacity.

In Their Own Words

“TCV is a special place with a long history of backing some of the world’s most innovative technology companies that have impacted all our lives. I’m grateful to the firm, my colleagues, and all the entrepreneurs I’ve had the great fortune of working with and learning from in building my career here over the past decade.” — Matt Robinson, GrowthCap Top 40 Under 40 profile, 2022 ³.

No additional independently sourced direct quotes from Robinson were found in press coverage, podcasts, or social media. Robinson maintains a relatively low public profile for a growth-stage investor who has deployed $700M+.

What Founders Say

No independently sourced founder testimonials specifically about Matt Robinson were found after dedicated searching across press coverage, podcasts, Twitter/X, and founder review platforms.

George Mulhern, CEO of Cradlepoint (where Robinson served as a board director), referenced TCV’s investment approach in a blog post about the firm’s $89M Series C: “The best due diligence is watching a company do what they say they are going to do” — attributing this philosophy to TCV ¹⁶. This quote references TCV as a firm rather than Robinson specifically, and predates Robinson’s board service at Cradlepoint.

Sources